In Vitro Susceptibility Testing of Tedizolid against Isolates of Nocardia.

Abstract

There is a paucity of efficacious antimicrobials (especially oral) against clinically relevant species of Nocardia To date, all species of Nocardia have been susceptible to linezolid, the first commercially available oxazolidinone. Tedizolid is a new oxazolidinone with previously reported improved in vitro and in vivo (intracellular) potency against… (More)
DOI: 10.1128/AAC.01537-17

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.